ConductScience.org, home

Paper658121

Blockade of neuronal tryptamine receptors by metoclopramide.

Fozard JR and 1 other. Eur J Pharmacol, 1978. Cited by 140 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Blockade of neuronal tryptamine receptors by metoclopramide. Papers, record 658121. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/658121

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Blockade of neuronal tryptamine receptors by metoclopramide.
PubMed
Journal
Eur J Pharmacol
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
140
iCite
Relative citation ratio, by iCite
5.46
iCite
Revised in PubMed
2019-06-23
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fozard JRJ R
2Mobarok ALI ATA T

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MetoclopramideMajor topic
Receptors, SerotoninMajor topic
Sympathetic Nervous SystemMajor topic
Animals
Dimethylphenylpiperazinium Iodide
Female
Heart
Heart Rate
In Vitro Techniques
Male
Myocardial Contraction
Neurons
Rabbits
Serotonin

Source PubMed

Cited by31

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 140 citations.

PMIDTitleJournalYearIn PapersSource
34,882,284Prevention of Chemotherapy-Induced Nausea and Vomiting in the Older Patient: Optimizing Outcomes.Drugs Aging2022https://conductscience.org/library/papers/34882284PubMed
22,518,105Physiology and pathology of calcium signaling in the brain.Front Pharmacol2012https://conductscience.org/library/papers/22518105PubMed
21,356,241Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.Pharmacol Ther2011https://conductscience.org/library/papers/21356241PubMed
21,243,342Tramadol-induced adrenal insufficiency.Eur J Clin Pharmacol2011https://conductscience.org/library/papers/21243342PubMed
16,041,395Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.Br J Pharmacol2005https://conductscience.org/library/papers/16041395PubMed
10,473,023Intranasal metoclopramide.Drugs1999https://conductscience.org/library/papers/10473023PubMed
9,028,742Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.Drugs1997https://conductscience.org/library/papers/9028742PubMed
8,000,727Future of the management of emesis.Support Care Cancer1994https://conductscience.org/library/papers/8000727PubMed
7,694,755An electrophysiological investigation of the properties of 5-HT3 receptors of rabbit nodose ganglion neurones in culture.Br J Pharmacol1993https://conductscience.org/library/papers/7694755PubMed
7,357,206Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature.Br J Pharmacol1980https://conductscience.org/library/papers/7357206PubMed
7,110,382The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum.Naunyn Schmiedebergs Arch Pharmacol1982https://conductscience.org/library/papers/7110382PubMed
7,052,342Antagonism of 5-hydroxytryptamine receptors by quipazine.Br J Pharmacol1980https://conductscience.org/library/papers/7052342PubMed
6,646,239
Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves.
Naunyn Schmiedebergs Arch Pharmacol1983https://conductscience.org/library/papers/6646239PubMed
6,472,484MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.Naunyn Schmiedebergs Arch Pharmacol1984https://conductscience.org/library/papers/6472484PubMed
3,990,828The depolarizing action of 5-hydroxytryptamine on rabbit vagal primary afferent and sympathetic neurones and its selective blockade by MDL 72222.Naunyn Schmiedebergs Arch Pharmacol1985https://conductscience.org/library/papers/3990828PubMed
3,814,920Pharmacological characterization of 5-hydroxytryptamine-induced depolarization of the rat isolated vagus nerve.Br J Pharmacol1987https://conductscience.org/library/papers/3814920PubMed
3,755,366The depolarizing action of 5-hydroxytryptamine on rabbit vagal afferent and sympathetic neurones in vitro and its selective blockade by ICS 205-930.Br J Pharmacol1986https://conductscience.org/library/papers/3755366PubMed
3,198,000Effect of ICS 205-930 (a specific 5-HT3 receptor antagonist) on gastric emptying of a solid meal in normal subjects.Gut1988https://conductscience.org/library/papers/3198000PubMed
3,161,573Two types of receptors for 5-hydroxytryptamine on the cholinergic nerves of the guinea-pig myenteric plexus.Br J Pharmacol1985https://conductscience.org/library/papers/3161573PubMed
2,969,949Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors?J Neural Transm1988https://conductscience.org/library/papers/2969949PubMed

See all 31 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/658121

GET https://conductscience.org/api/papers/v1/658121/cited_by?page=2